Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Coral

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Pharmacology & Therapeutics|January 4, 2014
Epigenetic drugs as immunomodulators for combination therapies in solid tumorsLuca Sigalotti, Elisabetta Fratta, Sandra Coral, et al.
Oncogene|October 7, 2003
Epigenetic targets for immune intervention in human malignanciesMichele Maio, Sandra Coral, Elisabetta Fratta, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Epigenetic markers of prognosis in melanomaLuca Sigalotti, Elisabetta Fratta, Giulia Parisi, et al.
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Cancer testis antigens and melanoma stem cells: new promises for therapeutic interventionLuca Sigalotti, Alessia Covre, Hugues J M Nicolay, et al.
International Journal of Cancer|April 22, 2003
Methylation-regulated expression of HLA class I antigens in melanomaEster Fonsatti, Luca Sigalotti, Sandra Coral, et al.
Seminars in Oncology|May 13, 2015
Epigenetics meets immune checkpointsAlessia Covre, Sandra Coral, Anna Maria Di Giacomo, et al.
Cancer Research|March 17, 2007
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man storySandra Coral, Luca Sigalotti, Alessia Covre, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanomaLuca Sigalotti, Sandra Coral, Gianpaolo Nardi, et al.
Seminars in Oncology|October 8, 2005
Epigenetic modulation of solid tumors as a novel approach for cancer immunotherapyLuca Sigalotti, Sandra Coral, Elisabetta Fratta, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Pharmacology & Therapeutics|January 4, 2014
Epigenetic drugs as immunomodulators for combination therapies in solid tumorsLuca Sigalotti, Elisabetta Fratta, Sandra Coral, et al.
Oncogene|October 7, 2003
Epigenetic targets for immune intervention in human malignanciesMichele Maio, Sandra Coral, Elisabetta Fratta, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2013
Epigenetic markers of prognosis in melanomaLuca Sigalotti, Elisabetta Fratta, Giulia Parisi, et al.
Immunotherapy|October 4, 2013
Epigenetics of melanoma: implications for immune-based therapiesElisabetta Fratta, Luca Sigalotti, Alessia Covre, et al.
Cancer Immunology, Immunotherapy : CII|October 29, 2009
Cancer testis antigens and melanoma stem cells: new promises for therapeutic interventionLuca Sigalotti, Alessia Covre, Hugues J M Nicolay, et al.
International Journal of Cancer|April 22, 2003
Methylation-regulated expression of HLA class I antigens in melanomaEster Fonsatti, Luca Sigalotti, Sandra Coral, et al.
Seminars in Oncology|May 13, 2015
Epigenetics meets immune checkpointsAlessia Covre, Sandra Coral, Anna Maria Di Giacomo, et al.
Cancer Research|March 17, 2007
5-AZA-2'-deoxycytidine in cancer immunotherapy: a mouse to man storySandra Coral, Luca Sigalotti, Alessia Covre, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanomaLuca Sigalotti, Sandra Coral, Gianpaolo Nardi, et al.
Seminars in Oncology|October 8, 2005
Epigenetic modulation of solid tumors as a novel approach for cancer immunotherapyLuca Sigalotti, Sandra Coral, Elisabetta Fratta, et al.
Pageof 4